Yuejin Yang

Chinese Academy of Medical Sciences & Peking Union Medical College — China

Medicine · Health Sciences

49h-index11.5kcitations553works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Coronary Interventions and Diagnostics(257), Acute Myocardial Infarction Research(167), Antiplatelet Therapy and Cardiovascular Diseases(132), Cardiac Imaging and Diagnostics(88), Cardiac Valve Diseases and Treatments(48)

Publications545 total

Impact of Glucose Metabolism Status on the Association between Apolipoprotein A-I and Ischemic Risk in Patients with Coronary Artery Disease: A Large-Sample Cohort Study
Endocrinology and Metabolism·2025Open Access
Association of Remnant Cholesterol with Platelet Reactivity in Coronary Artery Disease Patients Receiving PCI
Global Heart·2025Open Access
Percutaneous Endocardial Alginate–Hydrogel Injection in the Treatment of Heart Failure: First-in-Human Study
ESC Heart Failure·2025Open Access
Firesorb bioresorbable scaffold for de novo coronary artery disease: 1-year clinical outcomes
BMC Medicine·2025· 3 citedOpen Access
Prognostic value of C-reactive protein to albumin ratio in patients with valvular heart disease: nationwide prospective cohort study
International Journal of Surgery·2025· 1 citedOpen Access
The relationship between ABO blood types and clopidogrel-related low on-treatment platelet reactivity in patients with coronary artery diseases and type 2 diabetes mellitus: a secondary analysis of a prospective cohort study
Diabetology & Metabolic Syndrome·2025Open Access
Cardiovascular Risk Factors in Patients with Valvular Heart Disease: A Nationwide Observational Cohort Study
International Journal of General Medicine·2024· 3 citedOpen Access
Prognostic value of Glasgow Prognostic Score and its modified scores on 5-year outcome in patients with coronary heart disease undergoing percutaneous coronary intervention
Heliyon·2024· 2 citedOpen Access
Long-Term Outcomes of Sex Differences in Three-Vessel Coronary Disease with Different Treatment Strategies: A Large Cohort Study
Global Heart·2024· 1 citedOpen Access
Associations of HDL-C and ApoA-I with Mortality Risk in PCI Patients Across Different hsCRP Levels
Journal of Inflammation Research·2024· 2 citedOpen Access
Integrating depression and acute coronary syndrome care in low resource hospitals in China: the I-CARE randomised clinical trial
The Lancet Regional Health - Western Pacific·2024· 2 citedOpen Access
Long-term efficacy, safety and biocompatibility of a novel sirolimus eluting iron bioresorbable scaffold in a porcine model
Bioactive Materials·2024· 4 citedOpen Access
Inflammation and Insulin Resistance-Derived Indicator Predicts Adverse Cardiovascular Outcomes in Heart Failure Patients Undergoing Percutaneous Coronary Intervention
Research Square (Research Square)·2024Open Access
Effects of the stress hyperglycemia ratio on long-term mortality in patients with triple-vessel disease and acute coronary syndrome
Cardiovascular Diabetology·2024· 25 citedOpen Access
Inflammation modifies the platelet reactivity among thrombocytopenia patients undergoing percutaneous coronary intervention
Platelets·2024· 1 citedOpen Access
Post-procedural elevated cardiac troponin I and the association with 5-year mortality in patients undergoing elective PCI
Heliyon·2024Open Access
Cost-Effectiveness of Salt Substitute and Salt Supply Restriction in Eldercare Facilities
JAMA Network Open·2024· 14 citedOpen Access
Renal function alters the association of lipoprotein(a) with cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a prospective cohort study
Clinical Kidney Journal·2024· 7 citedOpen Access
Elevated High-Sensitivity C-Reactive Protein Level Enhances the Impact of Lipoprotein(a) on Platelet Reactivity in PCI Patients Treated with Clopidogrel
Clinical and Applied Thrombosis/Hemostasis·2024· 1 citedOpen Access
Design and Rationale of Early Initiation of Tafolecimab in Patients of Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Multicenter, Randomized Control Trial (Empact Trial)
SSRN Electronic Journal·2024Open Access
page 1 of 28Next →

Frequent Co-authors

Bo Xu(19), Yuejin Yang(13), Shubin Qiao(11), Zengwu Wang(7), Yongjian Wu(7), Yaling Han(6), Hongbing Yan(5), Yangfeng Wu(5), Gregg W. Stone(5), Yanyan Zhao(5), Changdong Guan(5), Jue Chen(5), Shengshou Hu(4), Zuo Chen(4), Congyi Zheng(4), Yuting Kang(4), Xi Su(4), Yi‐Da Tang(4), Jian Tian(4), Patrick W. Serruys(4)